APA (7th ed.) Citation

R, G., K, S., L, Z., S, Y., M, B., & M, M. (2026). Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients. Clinical pharmacokinetics, 65(4), 609. https://doi.org/10.1007/s40262-026-01625-5

Chicago Style (17th ed.) Citation

R, Goldstein, Sandouka K, Zighan L, Ya'ari S, Bialer M, and Muszkat M. "Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients." Clinical Pharmacokinetics 65, no. 4 (2026): 609. https://doi.org/10.1007/s40262-026-01625-5.

MLA (9th ed.) Citation

R, Goldstein, et al. "Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients." Clinical Pharmacokinetics, vol. 65, no. 4, 2026, p. 609, https://doi.org/10.1007/s40262-026-01625-5.